Veru Sets Q1 2027 for PLATEAU Trial Interim Analysis
The biopharma company completes enrollment of 239 patients for its late-stage study, targeting early 2027 data readout. Veru Inc. has finalized enrollment for its PLATEAU trial, reaching 239 patients, and plans an interim analysis in Q1 2027. The milestone accelerates the